What ‘unbelievable demand’ for weight-loss drugs adds up to for maker Lilly
Increased manufacturing capacity for Eli Lilly’s highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by $3 billion on Thursday, and its share jumped as…